It is currently in Phase 3 for alcohol use disorder (the RENEW-ALC-1 and RENEW-ALC-2 trials, 1,100 patients each) and in earlier-stage development for bipolar disorder, major depressive disorder, smoking withdrawal, asthma, cardiovascular and liver disorders, and obesity
Enter your concentration and desired dose
If youre researching compounded tirzepatide but confused about pricing, understanding the cost breakdown by dosage, why prices vary between providers, and what factors affect affordability helps you find legitimate treatment at the best possible price
Certain people with diabetes need to inform the Driver and Vehicle Licensing Agency (DVLA)
Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
No changes were made to the endpoints for the comparison of tirzepatide versus dulaglutide in the expanded population because we observed high concordance with SURPASS-CVOT estimates in the primary composite endpoint as well as mortality in the benchmarking study